Our Company

Hememics Biotechnologies is transforming the future of diagnostics with breakthrough monolayer graphene technology. Our innovative, pocket-sized reader and advanced multiplexed-sensor chips deliver precise results for small-molecule and protein tests in just five minutes even in the toughest environments thanks to this technology’s resistance to dirt and contaminants.

​​

Serving multi-billion-dollar markets, we collaborate with industry leaders in drug testing, agriculture, biodefense, and emergency diagnostics. Hememics is on a mission to be the "Intel Inside" of graphene-based sensor technology, empowering partners to create next-generation diagnostic solutions.

​

Our platform features cost-effective, polymer-based, disposable sensors, eliminating the need for expensive silicon fabrication in clean rooms. By combining speed, accuracy, affordability, and ease of use, Hememics is redefining what is possible in diagnostic testing - making advanced healthcare and biosecurity more accessible than ever.